［1］ Tenesa A,Dunlop MG. New insights into the aetiology of colorectal
cancer from Genome-wide association studies［J］.Nat Rev Genet,
200 ,10( ): 5 - 5 .
［2］ Baylin SB, Herman JG, Graft JR, et a1．Alterations in DNA methylation：
afundamental aspect of neoplasia［J］. Adv CancerRes,1 , 2:1 1-1 .
［ ］ Zhu W, Qin W, Hewett JE, et a1. Quantitative evaluation of DNA hypermethylation
in malignant and benign breast tissue and fluids［ J］. Int J
Cancer,2010,12 (2): - 2.
［ ］ Jones P,Takai D.The role of DNA methylation in mammalian epigenetics
［J］. Science,2001,2 (55 2):10 -10 0.
［5］ Tomemofi T，Seki N，Suzuki Y，et a1．Isolation and characterization
of murine orthologne of PTP-BK［J］．Biochem Biophys Res Commun,
2000,2 ( ): - 1.
［ ］ Murata Y,Mori M,Kotani T,et a1.Tyrosine phosphorylation of R subtype
receptortype protein tyrosine phosphatases and their complex formations
with Grb2 or Fyn［J］．Genes Cells,2010,15(5):51 -52 .
［ ］ Laezmanska I，Sasiadek MM．Tyrosine phosphatases as a superfamily
of tumor suppressors in colorectal cancer［J］.Acta Biochim
Pol,2011,5 ( ): - 0.
［ ］ Motiwala T，Kutay H，Ghoshal K，et a1．Protein tyrosine phosphatase
receptortype O(PTPR0)exhibits characteristics of a candidate tumor
suppressor in human lung cancer［J］.Proc Natl Acad Sci USA,200 ,101(
):1 -1 .
［ ］ Arimura Y，Yagi J．Comprehensive expression profiles of genes for protein
tyrosine phosphatases in immune cells［J］.Sci Signal,2010, (1 ):
rsl.
［10］ Andersen JN,Jansen PG,Echwald SM,et a1.A genomie perspective onprotein tyrosine phosphatases：gene structure，pseudogenes，and genetic
disease linkage［J］．FASEB J,200 ,1 ： - 0.
［11］ Motiwala T,Majumder S, Ghoshal K ,et al . PTPROt inactivates the
oncogenic fusion protein BCR/ABL and suppresses transformation of
K5 2 cells［J］. J Biol. Chem, 200 , 2 (1): 55- .
［12］ Motiwala T,Majumder S,Kutay H,et a1．Methylation and silencing of
protein tyrosine phosphatase receptor type 0 in chronic lymphocytic
leukemia［J］.Clin Cancer Res,200 ,1 (11): 1 - 1 1.
［1 ］ You YJ，Chen YP，Zheng XX，et a1．Aberrant methylation of thePTPRO
gene in peripheral blood as a potential biomarker in esophageaI squmnous
cell carcinoma patients［J］.Cancer Letters,2012, 15:1 -1 .